Wright, MM, Schopfer FJ, Baker PRS, Vidyasagar V., Powell P, Chumley P, Iles KE, Freeman BA, Agarwal, A. Fatty acid transduction of nitric oxide signaling: Nitrolinoleic acid potently activates endothelial heme oxygenase-1 expression. Proc Natl Acad Sci, USA, 2006; 103:4299-4304.
Hock TD, Liby K, Wright MM, McConnel S, Schorpp-Kistner M, Ryan TM, Agarwal A. JunB and JunD regulate human heme oxygenase-1 expression in renal epithelial cells. J Biol Chem 2007;282-6875-86.
Deshane J, Shen S, Chen B, Callabero S, Grochot-Przeczek A, Was H, Li Calzi S, Radoslaw L, Hock TD, Hill-Kapturczak N, Siegal GP, Dulak J, Jozhowicz A, Grant M, Agarwal A. Stromal cell-derived factor-1 promotes angiogenesis via a heme oxygenase-1 dependent mechanism. J Exp Med, 2007;204:605-618.
Suzanne Bergman, M.D.
Bergman SM. Morbidity of Patients with Tunneled Catheters. Jj Am Soc Nephrol. 12:1450, 2001.
Cross S, Bergman SM. Calciphylaxis: A Disease of Excessively Obese Women on Dialysis. J Am Soc Nephrol. 12:1924,2001.
Ruth Campbell, M.D.
Ruth C. Campbell MD, Xuemei Sui MD, MPH, Gerasimos Filippatos MD, Thomas E. Love PhD, Christy Wahle BA, Paul W. Sanders MD, Ali Ahmed MD, MPH. Association of Chronic Kidney Disease and Outcomes in Chronic Heart Failure. A Propensity-Matched Study. Nephrology 2008. August 18.
Campbell R, Sangalli F, Perticucci E, Aros C, Viscarra C, Perna A, Remuzzi A, Bertocchi F, Fagiani L, Remuzzi G, Ruggenenti P. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney International 2003, March 63(3):1094-1103.
Sumant Chugh, M.D.
Clement L, Liu G, Perez-Torres I, Kanwar YS, Avila-Casado C and Chugh SS. Early changes in gene expression that influence the course of primary glomerular disease. Kidney Int. 2007;72:337-347.
Chugh SS. Transcriptional regulation of podocyte disease. Transl Res 2007;149:237-242.
Liu G, Clement L, Kanwar YS, Avila-Casado C and Chugh SS. ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome. J Biol Chem 2006, 281;39681-39692.
Liu G, Kaw B, Kurfis J, Rahmanuddin S, Kanwar YS, Chugh SS. Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. J Clin Invest 2003;112:209-221.
John Curtis, M.D.
Curtis JJ: Corticosteroids and Kidney Transplantation. Clin J Am Soc Nephrol 1: 07-908, 2006.
Curtis JJ: Protocol biopsy: Today's fine-needle aspiration biopsy. Transplantation 84:77-678, 2007.
Robert Gaston, M.D.
Hippen BE, DeMattos A, Cook WJ, Kew CE,
Gaston RS. Association of CD20-positive infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant 5: 2248-2252, 2005.
Bernatt JL, d'Alessandro AM, Port FK, Bleck TP, Heart SO, Medina J, Rosenbaum SH, Gaston RS, et al. The report of a national conference on donation after cardiat death. Am J. Transplant 6: 281-291, 2006.
Gaston RS, Danovitch GM, Epstein RA, Kahn JP, Matas AJ, Schnitzler MA. Must all living donor compensation be viewed as valuable consideration? Am J Transplant 7: 1309-10, 2007.
Bruce Julian, M.D.
Chandrakantan A, Ratanapanichkich P, Said M, Barker CV, Julian BA. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil. Nephrol Dial Transplant 20:1214-1221, 2005.
Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Tomino Y, Mestecky J, Novak J. IgA1-secreting cells lines from patients with IgA nephropathy produce aberrantly-glycosylated IgA1. J Clin Invest 118:000-000, 2008.
Clifton Kew II, M.D.
Kew II CE, Lopez-Ben R, Smith JK, Robbin ML, Cook WJ, Gaston RS, Deierhoi MH, Julian BA. Posttransplant Lymphoproliferative Disorder Localized Near the Allograt in Renal Transplantation. Transplantation 2000 (March 15): Vol 69: No 5: pp809-814.
Young CJ, Kew II CE. Health Disparities in Transplantation: Focus on the Complexity and Challenge of Renal Transplantation in African-Americans. Medical Clinics of North America. 89(2005) 1003-1031.
Vinetta Kumar, M.D.
A.K. Diehl, V. Kumar, Gateley A, Appleby J.L., O'Keefe M.E. Predictors of Final Speciality Choice by Internal Medicine Residents J Gen Intern Med 2006;21:1045-1049.
Iozzo P, Pratipanawatr T, Pijl H, Vogt C, Kumar V, Pipek R, Matsuda M. Mandarino LJ, Cusi KJ, DeFonzo RA. Physiologic hyperinsulinemia impairs insulin-stimulated glycogen synthetase activity and glycogen synthesis. American Journal of Physiology-Endocrinology & Metabolis 2001 May; 280(5): E712-9.
Heping Ma, M.D.
Ma H, Matsunaga H, Li B, Schieffer B, Marrero MB, and Ling BN. Ca2+ channel activation by PDGF-induced tyrosine phosphorylation and RAS GTP-binding proteins in rat glomerular mesangial cells. J. Clin. Invest. 97:2332-2341, 1996.
Bao HF, Zhang ZR, Liang YY, Ma JJ, Eaton DC and Ma H-P. Ceramide mediates inhibition of the renal epithelial sodium channel by tumor necrosis factor-a through protein kinase C. Am J Physiol Renal Physiol 293: F1178-F1186, 2007.
Wei S-P, Li X-Q, Liang Y-Y, Peng J-B, Warnock DG and Ma H-P. Membrance tension modulates the effects of apical cholesterol on the renal epithelial sodium channel. J Membr Biol 220: 21, 2007.
Ivan Maya, M.D.
Maya ID, Allon M. Outcomes of thrombosed arterio-venous grafts in hemodialysis patients: Comparison of stents versus angioplasty. Kidney International. Vol 69 (2006), pp. 934-937.
Maya ID, Maddela P, Allon M. Percutaneous renal biopsy: Comparison of blind and real-time ultrasound-guided technique. Seminars in Dialysis - Vol 20, N 4 (July-August) 2007 pp 355-358.
Britt Newsome, M.D.
Newsome BB, Warnock DG, McClellan WM, Herzog C, Kiefe CI, Eggers P, Allison JJ. Long-Term Risk of Mortality and End State Renal Disease among the Elderly after Small Increases in Serum Creatinine during Acute Myocardial Infarction Hospitalization. (In Press, Archives of Internal Medicine, Manuscript #IMD07-1390-R2.)
Newsome BB, McClellan WM, Coffey CS, Allison JJ, Kiefe CI, Warnock DG. Survival Advantage of African American with Kidney Disease after Acute Myocardial Infarction. Clin J Am Soc Nephrol, 2006. 1: p. 9933-1000.
Mary Prendergast, M.D.
Prendergast M & Tolwani A: A Simple Trisodium Citrate Protocol that Provides Metabolic Control and High Solute Clearance in Continuous Renal Replacement Therapy. Journal of Investigative Medicine, Vol 52, #1. January 2004 (abstract publication).
Ashita J. Tolwani, Mary B Prendergast, et al: A Practical Citrate Anticoagulation Continueous Venovenous Hemodiafiltration Protocol for Metabolic Control and High Solute Clearance. Clinical Journal American Society of Nephrology (CJASN) 1:79-87, 2006.
Stephen Rostand, M.D
SG Rostand, SP Cliver, RL Goldenberg. Racial Disparities in the Association of Fetal Growth Retardation to Childhood Blood Pressure. Nephrol Dial Transplant 2005; 20: 1592-1597.
Gail E. Peterson, MD, Tine de Baker, MD, Avril Gabriel*, Vladimir Ilic, MD, Tudor Vagaonescu, MD, Larry Appel, MD, MPH, Gabriel Contreras, MD, Cindy Kendrick, Stephen Rostand, MD, and Robert Phillips, MD, Ph.D. Prevalence and Correlates of Left Ventricular Hypertrophy in the African American Study of Kidney Disease Cohort Study. Hypertension. 2007; 50:1-7.
Edwin Rutsky, M.D.
Evans RW, Rader B, Manninen DL and the Cooperative Multicenter EPO Clinical Trial Group. the quality of life of hemodialysis recipients treated with recombinant humanerythropoietin. JAMA 1990: 263:825-830.
Rutsky EA, Dubovsky EV, Kirk KA. Long-term follow-up of a human subject with a remnant kidney. Am J Kidney Dis 1991: 18:509-513.
Denyse Thornley-Brown, M.D.
Lowenthal EA, Mayo MS, Cornwell PE, and Thornley-Brown D. Homocysteine elevation in sickle cell disease. Journal of the American College of Nutrition 2000, 19:608-612.
Lewis J, Agodoa L, Cheek D, and the African American Study of Hypertension and Kidney Disease. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. American Journal of Kidney Disease 2001, 38:744-753.
Rostand SG, Thornley-Brown D. Soft tissue calcifation in chronic renal failure, in TB Drueke and I. Salusky, eds. the Spectrum of Renal Osteodystrophy (Oxford Clinical Nephrology Series) London, Oxfort University Press, 2001.
Ashita Tolwani, M.D.
Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA. Contineous renal replacement therapy: A worldwide practice survey: The Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Intensive Care Med; 208;9:1563-70.
Tolwani A, Prendergast M, Speer R, Stofan B, Wille K. A practical anticoagulation CVVHDF protocol for metabolic control and high solute clearance. CJASN 2006 January;1:79-87.